Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoann Pradat

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|March 26, 2026
fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretationKillian Maudet, Juliette Samaniego, Yoann Pradat, et al.
Plos Computational Biology|March 6, 2023
CustOmics: A versatile deep-learning based strategy for multi-omics integrationHakim Benkirane, Yoann Pradat, Stefan Michiels, et al.
Cancer Discovery|March 2, 2023
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic CancerYoann Pradat, Julien Viot, Andrey A Yurchenko, et al.
Cancer Discovery|June 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial CancerFrancesco Facchinetti, Antoine Hollebecque, Floriane Braye, et al.
Nature Communications|August 8, 2022
Unified classification and risk-stratification in Acute Myeloid LeukemiaYanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Nature Medicine|September 4, 2025
Patritumab deruxtecan in HR<sup>+</sup>HER2<sup>-</sup> advanced breast cancer: a phase 2 trialBarbara Pistilli, Fernanda Mosele, Noemie Corcos, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|March 26, 2026
fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretationKillian Maudet, Juliette Samaniego, Yoann Pradat, et al.
Plos Computational Biology|March 6, 2023
CustOmics: A versatile deep-learning based strategy for multi-omics integrationHakim Benkirane, Yoann Pradat, Stefan Michiels, et al.
Cancer Discovery|March 2, 2023
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic CancerYoann Pradat, Julien Viot, Andrey A Yurchenko, et al.
Cancer Discovery|June 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial CancerFrancesco Facchinetti, Antoine Hollebecque, Floriane Braye, et al.
Nature Communications|August 8, 2022
Unified classification and risk-stratification in Acute Myeloid LeukemiaYanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Nature Medicine|September 4, 2025
Patritumab deruxtecan in HR<sup>+</sup>HER2<sup>-</sup> advanced breast cancer: a phase 2 trialBarbara Pistilli, Fernanda Mosele, Noemie Corcos, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 1